Cargando…
Ivermectin for the prevention of COVID-19: addressing potential bias and medical fraud
BACKGROUND: Ivermectin is an antiparasitic drug being investigated in clinical trials for the prevention of COVID-19. However, there are concerns about the quality of some of these trials. OBJECTIVES: To conduct a meta-analysis with randomized controlled trials of ivermectin for the prevention of CO...
Autores principales: | Hill, Andrew, Mirchandani, Manya, Ellis, Leah, Pilkington, Victoria |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326581/ https://www.ncbi.nlm.nih.gov/pubmed/35190831 http://dx.doi.org/10.1093/jac/dkac052 |
Ejemplares similares
-
Ivermectin for COVID-19: Addressing Potential Bias and Medical Fraud
por: Hill, Andrew, et al.
Publicado: (2022) -
529. Systematic Review and Meta-Analysis of Ivermectin Safety Profile in COVID-19 Trials
por: Wentzel, Hannah, et al.
Publicado: (2021) -
Efficacy of Approved Versus Unapproved Vaccines for Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Randomized Blinded Clinical Trials
por: Perez Navarro, Andrea, et al.
Publicado: (2022) -
Retracted: Meta-analysis of Randomized Trials of Ivermectin to Treat
SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2021) -
Retraction to: Meta-analysis of Randomized Trials of Ivermectin to Treat
SARS-CoV-2 Infection
por: Hill, Andrew, et al.
Publicado: (2022)